The frequency of high blood glucose among patients receiving PI3K/Akt inhibitors to treat breast cancer has some oncologists ...

GP leaders will vote on demanding payment for any additional work transferred to general practice from secondary care.

A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between ...

The future of treating metabolic dysfunction–associated steatohepatitis (MASH) looks brighter than ever, says Naim Alkhouri, MD, as data emerges on newly developed interventions.

Stimulating a receptor in adipocytes enhanced energy expenditure and caused sustained weight loss in mice, offering targets ...

Based, GLP-1 Inspired Weight Loss Supplement as a Natural Alternative to Mounjaro in 2025Aurora, Colorado, April 23, ...

Nourish, a virtual nutrition counseling startup, has raised $70 million in a series B round.  | Nourish connects patients ...

Glucagon-like peptide 1 receptor agonists, which are found in Ozempic-like drugs, can could cause devastating symptoms in ...

Board Certified in Endocrinology, Diabetes, and Metabolism and Internal Medicine, Dr. Caveney leads IQVIA’s Obesity, ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

Discover if eating just 5 specific nuts can actually control hunger all morning long. Science reveals how these ...

Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...